Comments on: Pradaxa® (dabigatran etexilate) dual therapy showed lower rates of major bleeding versus triple therapy with warfarin in atrial fibrillation patients undergoing stent placement

Comments on: Pradaxa® (dabigatran etexilate) dual therapy showed lower rates of major bleeding versus triple therapy with warfarin in atrial fibrillation patients undergoing stent placement https://www.novumpr.nl/2017/08/28/pradaxa-dabigatran-etexilate-dual-therapy-showed-lower-rates-of-major-bleeding-versus-triple-therapy-with-warfarin-in-atrial-fibrillation-patients-undergoing-stent-placement/?utm_source=rss&utm_medium=rss&utm_campaign=pradaxa-dabigatran-etexilate-dual-therapy-showed-lower-rates-of-major-bleeding-versus-triple-therapy-with-warfarin-in-atrial-fibrillation-patients-undergoing-stent-placement NovumPR press releases Mon, 28 Aug 2017 07:32:55 +0000 hourly 1 https://wordpress.org/?v=6.8.3